Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/12/2011EP1912963B1 Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease
10/12/2011EP1909783B1 Illudin analogs useful as anticancer agents
10/12/2011EP1893191B1 Medicinal acidic cannabinoids
10/12/2011EP1871400B1 Uronic acid and probiotics
10/12/2011EP1861391B1 Methods for preparing substituted sulfoxide compounds
10/12/2011EP1853266B1 2s,4r ketoconazole for treating diabetes, metabolic syndrome and other conditions
10/12/2011EP1807064B1 Cyanoacrylate monomer formulation containing diiodomethyl-p-tolylsulfone and hydroxydiphenyl ether
10/12/2011EP1778238B1 Dihydropteridinone infusion solution having a long shelf life
10/12/2011EP1761522B1 Compounds and methods for treating dyslipidemia
10/12/2011EP1695955B1 Compounds having lysophosphatidic acid receptor antagonism and uses thereof
10/12/2011EP1656349B1 Cyclopropyl derivatives as nk3 receptor antagonists
10/12/2011EP1656143B1 Novel use of quinolone antibiotics
10/12/2011EP1652923B1 Gene overexpressed in cancer
10/12/2011EP1534285B1 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes
10/12/2011EP1525884B1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
10/12/2011EP1448995B9 Assay for screening candidate drugs for the treatment of inflammatory diseases
10/12/2011EP1385820B1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
10/12/2011EP1366022B1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
10/12/2011EP1294377B1 Methods and compositions for the treatment of alcoholism and alcohol dependence
10/12/2011EP1221851B2 Antiviral compositions for tissue paper
10/12/2011CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011CN1953770B X-ray visible drug delivery device
10/12/2011CN1934101B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/12/2011CN1849318B Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/12/2011CN1473265B Method for producing purified hematinic iron-saccharidic complex and product produced
10/12/2011CN102216458A Antisense compositions and methods of making and using same
10/12/2011CN102216381A Rehydratable polysaccharide particles and sponge
10/12/2011CN102216376A Surface modification of polymers via surface active and reactive end groups
10/12/2011CN102216334A Polysaccharides containing carboxyl functional groups substituted by a hydrophobic alcohol derivative
10/12/2011CN102216318A Antioxidant
10/12/2011CN102216317A Antioxidant
10/12/2011CN102216316A Substituted amine derivative and medicinal composition comprising same as the active ingredient
10/12/2011CN102216314A Crystalline polymorphs of gemcitabine base
10/12/2011CN102216310A Novel prostaglandin e1 derivative, and nanoparticle having same encapsulated therein
10/12/2011CN102216309A A triazolothiadiazole inhibitor of c-met protein kinase
10/12/2011CN102216308A [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials
10/12/2011CN102216307A Nitrogenous heterocyclic compounds, preparation thereof, and use thereof as antibacterial agents
10/12/2011CN102216306A Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound
10/12/2011CN102216305A Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
10/12/2011CN102216304A Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
10/12/2011CN102216302A Akt and p70 s6 kinase inhibitors
10/12/2011CN102216301A Novel combinations of antibacterial nitrogenous heterocyclic compounds with other antibacterial compounds, and use thereof as drugs
10/12/2011CN102216300A Compounds and compositions as protein kinase inhibitors
10/12/2011CN102216299A 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
10/12/2011CN102216298A Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors
10/12/2011CN102216297A (dihydro)pyrrolo[2,1-a]isoquinolines
10/12/2011CN102216295A 8-azabicyclo [3.2.1]oct-2-ene derivatives and their use as mono-amine neurotransmitter re-uptake inhibitors
10/12/2011CN102216292A Tetrasubstituted pyridazines HEDGEHOG pathway antagonists
10/12/2011CN102216291A Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
10/12/2011CN102216290A Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/12/2011CN102216289A Nicotinic acetylcholine receptor ligands and the uses thereof
10/12/2011CN102216285A Tetrasubstituted pyridazine hedgehog pathway antagonists
10/12/2011CN102216283A Quinazoline derivatives as NK3 receptor antagonists
10/12/2011CN102216282A Aryl piperazine and their use as alpha2c antagonists
10/12/2011CN102216281A Novel choline cocrystal of epalrestat
10/12/2011CN102216277A Novel compounds as cannabinoid receptor ligands
10/12/2011CN102216276A Heteroaryls amide derivatives and their use as glucokinase activators
10/12/2011CN102216273A Naphthylacetic acids used as crth2 antagonists or partial agonists
10/12/2011CN102216272A 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
10/12/2011CN102216271A Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
10/12/2011CN102216270A Novel bis-amides as antimalarial agents
10/12/2011CN102216268A Novel estrogen receptor ligands
10/12/2011CN102216265A Naphthylacetic acids
10/12/2011CN102216260A Amino acid derivative
10/12/2011CN102216257A GABA conjugates and methods of use thereof
10/12/2011CN102216249A Naphthylacetic acids
10/12/2011CN102215950A Ceramide dispersion, and process for producing same
10/12/2011CN102215900A Local embolization using thermosensitive polymers
10/12/2011CN102215870A Diagnosis method and therapeutic method for cancer
10/12/2011CN102215867A Composition for treating disease
10/12/2011CN102215857A Pharmaceutical composition containing ginger extract or shogaol
10/12/2011CN102215846A St cyr john a [us]; maccarter dean a
10/12/2011CN102215845A Solid state forms of a pharmaceutical
10/12/2011CN102215844A Folate receptor binding conjugates of antifolates
10/12/2011CN102215843A Antiprolactinic veterinary composition for ruminants
10/12/2011CN102215842A Therapeutic agent for chorioretinal degenerative diseases comprising pyridine-3-carbaldehyde o-(piperidin-1-yl-propyl)-oxime derivative as active ingredient
10/12/2011CN102215841A Immunomodulating activities
10/12/2011CN102215840A Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
10/12/2011CN102215839A Fat emulsion for artificially feeding seriously ill intensive care patients
10/12/2011CN102215838A Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms
10/12/2011CN102215837A Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
10/12/2011CN102215836A Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
10/12/2011CN102215835A A medicinal product and treatment
10/12/2011CN102215834A Guanylhydrazones for treatment of postoperative intestinal inflammation
10/12/2011CN102215833A Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
10/12/2011CN102215832A Pharmaceutical formulation between jasmonates and it derivatives and nanocarries or microcarri es
10/12/2011CN102215829A Prolonged release formulations comprising an 2 -oxo- 1 -pyrrolidine derivative
10/12/2011CN102215828A Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate
10/12/2011CN102215824A Solid pharmaceutical formulation with delayed release
10/12/2011CN102215823A Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient
10/12/2011CN102215822A Novel composition based on gamma-hydroxybutyric acid
10/12/2011CN102215818A Drug delivery system
10/12/2011CN102215812A Anti-wrinkle agents
10/12/2011CN102215811A Effervescent compositions
10/12/2011CN102215690A Antimicrobial compositions
10/12/2011CN102215689A Treatment for leukemia and idiopathic aplastic anemia
10/12/2011CN102215688A Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
10/12/2011CN102215683A Antimicrobial compositions and uses
10/12/2011CN102215682A Macrocyclic lactone compounds and methods for their use
10/12/2011CN102215681A Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
1 ... 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 ... 7860